The nightmare severity index (NSI): A short new multidimensional tool for assessing nightmares.

PTSD bad dreams dream content nightmare disorder nightmares sleep disorders

Journal

Journal of sleep research
ISSN: 1365-2869
Titre abrégé: J Sleep Res
Pays: England
ID NLM: 9214441

Informations de publication

Date de publication:
17 Oct 2023
Historique:
revised: 14 09 2023
received: 14 07 2023
accepted: 24 09 2023
medline: 17 10 2023
pubmed: 17 10 2023
entrez: 17 10 2023
Statut: aheadofprint

Résumé

This psychometric pilot study aims to evaluate a new multidimensional simple scale, named the nightmare severity index (NSI) - close to the existing insomnia (ISI) and hypersomnia (HSI) severity indexes. The NSI encompasses all main dimensions of nightmare disorder, evaluating four subdimensions: frequency, emotional impact, diurnal impact, and nocturnal impact of nightmares. The NSI was completed by a total of 102 patients. The majority of the population consisted of women (64%) and outpatient individuals (76%) diagnosed with mood disorders such as depression (31%) and bipolar disorder (41%). Comorbidity with post-traumatic stress disorder (PTSD) was prevalent (44%), and psychotropic medications were commonly used (47%). Internal validity analyses indicated that the NSI was well suited for exploratory factor analysis. All items demonstrated satisfactory correlations with the factors, and the questionnaire exhibited good internal consistency (Cronbach's alpha >0.7). Higher NSI scores were observed among individuals experiencing nightmare symptoms considering the DSM-5/ICSD-3 criteria. In summary, the NSI proves to be a promising and valuable tool for clinical practice, demonstrating good acceptability, internal validity, and the ability to assess nightmare severity.

Identifiants

pubmed: 37846776
doi: 10.1111/jsr.14065
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14065

Informations de copyright

© 2023 The Authors. Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Sleep Research Society.

Références

Ağargün, M. Y., Cilli, A. S., Kara, H., Tarhan, N., Kincir, F., & Oz, H. (1998). Repetitive and frightening dreams and suicidal behavior in patients with major depression. Comprehensive Psychiatry, 39(4), 198-202. https://doi.org/10.1016/s0010-440x(98)90060-8
Akkaoui, M. A., Lejoyeux, M., d'Ortho, M.-P., & Geoffroy, P. A. (2020). Nightmares in patients with major depressive disorder, bipolar disorder, and psychotic disorders: A systematic review. Journal of Clinical Medicine, 9(12), E3990. https://doi.org/10.3390/jcm9123990
Allen, S. F., Gardani, M., Akram, A., Irvine, K. R., & Akram., U. (2021). Examining the factor structure, reliability, and validity of the disturbing dreams and nightmare severity index (DDNSI) consequences sub-component. Behavioral Sleep Medicine, 19(6), 783-794. https://doi.org/10.1080/15402002.2020.1862848
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Amer Psychiatric Pub Incorporated.
American Academy of Sleep Medicine (AASM) ICSD-3 Online Version. (2014). AASM. Consulté 25 février 2016. http://www.aasmnet.org/store/product.aspx?pid=849
Bartlett, M. S. (1951). A further note on tests of significance in factor analysis. British Journal of Statistical Psychology, 4(1), 1-2. https://doi.org/10.1111/j.2044-8317.1951.tb00299.x
Bastien, C. H., Vallières, A., & Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2(4), 297-307. https://doi.org/10.1016/s1389-9457(00)00065-4
Belicki, K. (1992a). Nightmare frequency versus nightmare distress: Relations to psychopathology and cognitive style. Journal of Abnormal Psychology, 101(3), 592-597.
Belicki, K. (1992b). The relationship of nightmare frequency to nightmare suffering with implications for treatment and research. Dreaming, 2, 143-148.
Fabrigar, L. R., Wegener, D. T., MacCallum, R. C., & Strahan, E. J. (1999). Evaluating the use of exploratory factor analysis in psychological research. Psychological Methods, 4, 272-299. https://doi.org/10.1037/1082-989X.4.3.272
Garin, O. (2014). Ceiling effect. In A. C. Michalos (Ed.), Encyclopedia of quality of life and well-being research (pp. 631-633). Springer. https://doi.org/10.1007/978-94-007-0753-5_296
Geoffroy, P. A. (2023). How are you dreaming? A very simple question to screen for suicide risk. Bipolar Disorders https://doi.org/10.1111/bdi.13325
Geoffroy, P. A., Borand, R., Ambar Akkaoui, M., Yung, S., Atoui, Y., Fontenoy, E., Maruani, J., & Lejoyeux, M. (2022). Bad dreams and nightmares preceding suicidal behaviors. The Journal of Clinical Psychiatry, 84(1), 22m14448. https://doi.org/10.4088/JCP.22m14448
Kaplan, K. A., Plante, D. T., Cook, J. D., & Harvey, A. G. (2019). Development and validation of the (HSI): A measure to assess hypersomnia severity and impairment in psychiatric disorders. Psychiatry Research, 281, 112547. https://doi.org/10.1016/j.psychres.2019.112547
Krakow, B. (2006). Nightmare complaints in treatment-seeking patients in clinical sleep medicine settings: Diagnostic and treatment implications. Sleep, 29(10), 1313-1319. https://doi.org/10.1093/sleep/29.10.1313
Krakow, B., Hollifield, M., Schrader, R., Koss, M., Tandberg, D., Lauriello, J., McBride, L., Warner, T. D., Cheng, D., Edmond, T., & Kellner, R. (2000). A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: A preliminary report. Journal of Traumatic Stress, 13(4), 589-609. https://doi.org/10.1023/A:1007854015481
McHorney, C. A., & Tarlov, A. R. (1995). Individual-patient monitoring in clinical practice: Are available health status surveys adequate? Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 4(4), 293-307. https://doi.org/10.1007/BF01593882
Miró, E., & Martínez, M. P. (2005). Affective and personality characteristics in function of nightmare prevalence, nightmare distress, and interference due to nightmares. Dreaming, 15(2), 89-105. https://doi.org/10.1037/1053-0797.15.2.89
Robert, G., & Zadra, A. (2014). Thematic and content analysis of idiopathic nightmares and bad dreams. Sleep, 37(2), 409-417. https://doi.org/10.5665/sleep.3426
Scapin, F., Dehon, H., & Englebert, J. (2018). Assessment of a French version of the Mannheim Dream questionnaire (MADRE) in a Belgian sam- ple. International Journal of Dream Research, 11(1), 8.
Schmid, C., Hansen, K., Kröner-Borowik, T., & Steil, R. (2021). Imagery rescripting and imaginal exposure in nightmare disorder compared to positive imagery: A randomized controlled trial. Psychotherapy and Psychosomatics, 90(5), 328-340. https://doi.org/10.1159/000512757
Schredl, M., Berres, S., Klingauf, A., Schellhaas, S., & Göritz, A. S. (2014). The Mannheim Dream Questionnaire (MADRE): Retest reliability, age and gender effects. International Journal of Dream Research, 7(2), 141-147.
Seda, G., Sanchez-Ortuno, M. M., Welsh, C. H., Halbower, A. C., & Edinger, J. D. (2015). Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress. Journal of Clinical Sleep Medicine, 11(1), 11-22. https://doi.org/10.5664/jcsm.4354
Speed, K. J., Drapeau, C. W., & Nadorff, M. R. (2018). Differentiating single and multiple suicide attempters: What nightmares can tell us that other predictors cannot. Journal of Clinical Sleep Medicine, 14(5), 829-834. https://doi.org/10.5664/jcsm.7116
Tanskanen, A., Tuomilehto, J., Viinamäki, H., Vartiainen, E., Lehtonen, J., & Puska, P. (2001). Nightmares as predictors of suicide. Sleep, 24(7), 845-848. https://doi.org/10.1093/sleep/24.7.845
Waltman, S. H., Shearer, D., & Moore, B. A. (2018). Management of post-traumatic nightmares: A review of pharmacologic and nonpharmacologic treatments since 2013. Current Psychiatry Reports, 20(12), 108. https://doi.org/10.1007/s11920-018-0971-2
Wang, X., Cheng, S., & Xu, H. (2019). Systematic review and meta-analysis of the relationship between sleep disorders and suicidal behaviour in patients with depression. BMC Psychiatry, 19(1), 303. https://doi.org/10.1186/s12888-019-2302-5
Yücel, D. E., van Emmerik, A. A. P., Souama, C., & Lancee, J. (2020). Comparative efficacy of imagery rehearsal therapy and prazosin in the treatment of trauma-related nightmares in adults: A meta-analysis of randomized controlled trials. Sleep Medicine Reviews, 50, 101248. https://doi.org/10.1016/j.smrv.2019.101248
Zadra, A., & Donderi, D. C. (2000). Nightmares and bad dreams: Their prevalence and relationship to well-being. Journal of Abnormal Psychology, 109(2), 273-281.

Auteurs

Pierre A Geoffroy (PA)

Département de psychiatrie et d'addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hôpital Bichat - Claude Bernard, Paris, France.
Centre ChronoS, GHU Paris - Psychiatry & Neurosciences, Paris, France.
NeuroDiderot, Inserm, FHU I2-D2, Université Paris Cité, Paris, France.
Institute for Cellular and Integrative Neurosciences, CNRS UPR 3212, Strasbourg, France.

Emilie Stern (E)

Centre ChronoS, GHU Paris - Psychiatry & Neurosciences, Paris, France.

Julia Maruani (J)

Département de psychiatrie et d'addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hôpital Bichat - Claude Bernard, Paris, France.
Centre ChronoS, GHU Paris - Psychiatry & Neurosciences, Paris, France.
NeuroDiderot, Inserm, FHU I2-D2, Université Paris Cité, Paris, France.

Renaud Cornic (R)

Département d'Epidémiologie, Biostatistique et Recherche Clinique AP-HP, DMU PRISME, Hôpital Bichat - Claude Bernard, Paris, France.

Balthazar Bazin (B)

Département de psychiatrie et d'addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hôpital Bichat - Claude Bernard, Paris, France.
Centre ChronoS, GHU Paris - Psychiatry & Neurosciences, Paris, France.
NeuroDiderot, Inserm, FHU I2-D2, Université Paris Cité, Paris, France.

Emmanuelle Clerici (E)

Centre ChronoS, GHU Paris - Psychiatry & Neurosciences, Paris, France.

Marine Ambar Akkaoui (M)

Centre ChronoS, GHU Paris - Psychiatry & Neurosciences, Paris, France.
NeuroDiderot, Inserm, FHU I2-D2, Université Paris Cité, Paris, France.
Centre Psychiatrique d'Orientation et d'Accueil (CPOA), GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, Paris, France.

Régis Lopez (R)

Universite de Montpellier Faculte de Medecine Montpellier-Nimes, Montpellier, France.

Justine Frija Masson (J)

NeuroDiderot, Inserm, FHU I2-D2, Université Paris Cité, Paris, France.
Département de Physiologie - Explorations Fonctionnelles et Centre du Sommeil AP-HP, DMU DREAM, Hôpital Bichat - Claude Bernard, Paris, France.

Marie-Pia d'Ortho (MP)

NeuroDiderot, Inserm, FHU I2-D2, Université Paris Cité, Paris, France.
Département de Physiologie - Explorations Fonctionnelles et Centre du Sommeil AP-HP, DMU DREAM, Hôpital Bichat - Claude Bernard, Paris, France.

Michel Lejoyeux (M)

Département de psychiatrie et d'addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hôpital Bichat - Claude Bernard, Paris, France.
Centre ChronoS, GHU Paris - Psychiatry & Neurosciences, Paris, France.
NeuroDiderot, Inserm, FHU I2-D2, Université Paris Cité, Paris, France.

Jean-Arthur Micoulaud Franchi (JA)

University Sleep Medicine Department, University Hospital of Bordeaux, Bordeaux, France.
2 UMR CNRS 6033 SANPSY, University Hospital of Bordeaux, Bordeaux, France.

Camille Couffignal (C)

Département d'Epidémiologie, Biostatistique et Recherche Clinique AP-HP, DMU PRISME, Hôpital Bichat - Claude Bernard, Paris, France.

Classifications MeSH